Internal Medicine, Hematology & Oncology · Marietta, OH
NPI
1083607089
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
400 Matthew St
Marietta, OH, 45750
Phone (740) 376-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.1M
258,690 services
Medicare patients, 2024
789
Average age 73
Drug cost, 2024
$4.4M
1,562 prescriptions
Company payments, 2025
$391
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vivek V Abhyankar was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 38,240 times for 29 patients. In total Vivek V Abhyankar billed 258,690 services in 195 codes, and Medicare paid $5.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-16.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 38,240 | 29 | $2.32 | $89K |
| J9119 Injection, cemiplimab-rwlc, 1 mg | Office | 28,700 | 11 | $21.79 | $625K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 19,052 | 151 | $0.11 | $2,007 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,602 | 21 | $43.97 | $554K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,950 | 25 | $0.11 | $1,184 |
| J9267 Injection, paclitaxel, 1 mg | Office | 8,984 | 17 | $0.08 | $722 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 5,800 | 13 | $35.80 | $208K |
| J0897 Injection, denosumab, 1 mg | Office | 5,460 | 13 | $20.96 | $114K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,500 | 31 | $15.67 | $71K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,332 | 69 | $0.09 | $205 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,077 | 12 | $2.21 | $4,584 |
| Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 2,000 | 12 | $14.55 | $29K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,570 | 45 | $0.66 | $1,032 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 648 | 35 | $0.07 | $46.36 |
| 96372 Injection Administration | Office | 646 | 110 | $10.16 | $6,563 |
By year: 2022 $1.9M for 140,897 services; 2023 $3.8M for 221,924 services; 2024 $5.1M for 258,690 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 270 | 139 | $8.59 | $2,318 |
| 81002 Clinical Chemistry | 26 | 19 | $3.41 | $88.66 |
Medicare prescription drug claims, 2024
In 2024, the drug Vivek V Abhyankar prescribed most often to Medicare patients was Prednisone, with 120 prescriptions and refills. In total Vivek V Abhyankar wrote 1,562 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 120 | 182 | 38 | $533 |
| Anastrozole Generic | 89 | 219 | 29 | $1,641 |
| Dexamethasone Generic | 58 | 69 | 26 | $1,255 |
| Letrozole Generic | 55 | 109 | 15 | $679 |
| Ondansetron Hcl Generic | 44 | 46 | 31 | $2,798 |
| Acyclovir Generic | 43 | 69 | 17 | $662 |
| Hydroxyurea Generic | 42 | 110 | 15 | $959 |
| Abiraterone Acetate Generic | 38 | 38 | Under 11 | $113K |
| Alprazolam Generic | 33 | 39 | 11 | $233 |
| Brukinsa Zanubrutinib | 33 | 35 | Under 11 | $509K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 31 | 59 | 11 | $184 |
| Prochlorperazine Maleate Generic | 28 | 28 | 27 | $926 |
| Potassium Chloride Generic | 28 | 28 | Under 11 | $206 |
| Allopurinol Generic | 28 | 72 | 12 | $282 |
| Gabapentin Generic | 26 | 48 | 11 | $273 |
Brand drugs: 308 claims; generic drugs: 1,254 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vivek V Abhyankar $391 ($391 in general payments such as food, travel and fees) from 2 companies. The largest payer was BeOne Medicines USA, Inc. with $246.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.